Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China flag China · Delayed Price · Currency is CNY
57.95
+2.59 (4.68%)
At close: Mar 6, 2026

SHA:688513 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-971.4781.23830.971,051
Trading Asset Securities
-452.35741.78516.36453.84
Cash & Short-Term Investments
1,5661,4241,5231,3471,505
Cash Growth
10.00%-6.52%13.04%-10.45%-7.43%
Accounts Receivable
-288.44177.7180.92126.73
Other Receivables
-0.440.661.250.17
Receivables
-288.88178.36182.17126.9
Inventory
-190.09160.98140.87103.68
Prepaid Expenses
-4.224.112.783.2
Other Current Assets
-21.7616.4125.9740.76
Total Current Assets
-1,9291,8831,7091,779
Property, Plant & Equipment
-1,2491,2551,141874.59
Long-Term Investments
-80.7181.0846.66-
Other Intangible Assets
-35.634.4634.6133.71
Long-Term Deferred Tax Assets
-11.58.578.7312.16
Long-Term Deferred Charges
-77.5154.9245.3612.35
Other Long-Term Assets
-16.7329.8932.0963.39
Total Assets
-3,4003,3473,0182,775
Accounts Payable
-144.35180.94156.86203.92
Accrued Expenses
-266.85218.97190.72156.1
Short-Term Debt
-74.44180.95105.2920.02
Current Portion of Long-Term Debt
-3.672.93--
Current Income Taxes Payable
-4.623.341.462.71
Current Unearned Revenue
-38.2831.9828.7110.99
Other Current Liabilities
-64.1241.9846.3538.72
Total Current Liabilities
-596.32661.09529.39432.46
Long-Term Debt
-35.9339.6--
Long-Term Unearned Revenue
-68.2541.1842.8151.03
Long-Term Deferred Tax Liabilities
-1.71.460.880.12
Total Liabilities
-702.21743.33573.08483.6
Common Stock
-176.53120.09120.09120.09
Additional Paid-In Capital
-1,3881,4441,4441,444
Retained Earnings
-1,2081,040880.3727.45
Treasury Stock
--76.22-1.59--
Comprehensive Income & Other
-1.020.990.020.07
Shareholders' Equity
2,8662,6982,6032,4442,292
Total Liabilities & Equity
-3,4003,3473,0182,775
Total Debt
133.23114.04223.48105.2920.02
Net Cash (Debt)
1,4331,3101,3001,2421,485
Net Cash Growth
9.41%0.78%4.63%-16.33%-6.35%
Net Cash Per Share
8.257.487.347.038.43
Filing Date Shares Outstanding
166.7174.08174.93176.53176.53
Total Common Shares Outstanding
174.35174.08176.49176.53176.53
Working Capital
-1,3321,2221,1801,347
Book Value Per Share
16.4415.5014.7513.8512.98
Tangible Book Value
2,8322,6622,5692,4102,258
Tangible Book Value Per Share
16.2415.2914.5613.6512.79
Buildings
-775.81724.27487.54152.45
Machinery
-678.03661.8673.35279.81
Construction In Progress
-189.56186.26231.12637.88
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.